Previously submitted to: Journal of Medical Internet Research (no longer under consideration since May 07, 2026)
Date Submitted: Oct 21, 2025
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Exploring Knowledge Models Enabling Research Infrastructure in Cancer: A Systematic Review of Approaches
ABSTRACT
Background:
Cancer research increasingly relies on heterogeneous datasets such as electronic health records (EHRs), genomic sequences, imaging, and multi-omics data. Robust research infrastructures are required to integrate these sources, yet existing approaches remain fragmented. Knowledge models, including ontologies, taxonomies, and knowledge graphs, provide standardized frameworks for data structuring, interoperability, and reuse, but their effectiveness in oncology research is not fully synthesized.
Objective:
This study aimed to systematically review knowledge models applied in cancer research infrastructures and to evaluate their role in addressing data heterogeneity, scalability, We conducted a systematic literature review following the guidelines of Kitchenham and Charters and the PRISMA 2020 framework. Searches were performed in PubMed, Scopus, Web of Science, and other digital libraries for studies published between 2015 and 2025. Inclusion criteria required that articles describe or evaluate knowledge models used in cancer data repositories. Three reviewers independently screened and assessed studies using predefined quality criteria. Data extraction covered model type, application domain, data types, methodological approaches, and reported challenges. We summarized the findings in a PRISMA flow diagram. and interoperability.
Methods:
We conducted a systematic literature review following the guidelines of Kitchenham and Charters and the PRISMA 2020 framework. Searches were performed in PubMed, Scopus, Web of Science, and other digital libraries for studies published between 2015 and 2025. Inclusion criteria required that articles describe or evaluate knowledge models used in cancer data repositories. Three reviewers independently screened and assessed studies using predefined quality criteria. Data extraction covered model type, application domain, data types, methodological approaches, and reported challenges. We summarized the findings in a PRISMA flow diagram.
Results:
A total of 39 primary studies were included. Most studies (over 75%) employed formal ontologies, particularly the National Cancer Institute Thesaurus (NCIT) and Systematized Nomenclature of Medicine-Clinical Terms (SNOMED-CT), to ensure semantic interoperability. Knowledge graphs, thesauri, and taxonomies were also reported. The models were applied to genomics, proteomics, clinical trials, imaging, and patient-reported outcomes. Key contributions included enhanced semantic data integration, ontology-based data structuring, and improved information retrieval and decision support. Reported challenges included scalability limitations in large-scale applications, manual curation demands, ontology evolution, and restricted usability for clinicians. Opportunities highlighted in the literature involved machine learning-assisted ontology enrichment, modular architecture, and community-driven standards such as the Open Biological and Biomedical Ontologies (OBO) Foundry.
Conclusions:
Knowledge models are central to enabling interoperable and reusable infrastructures in cancer research. Ontologies and knowledge graphs provide essential foundations for semantic integration across heterogeneous biomedical data. Despite advances, challenges remain in scalability, sustainability, and real-world adoption within clinical workflows. Future research should prioritize automation, user-centered tools, and cross-institutional collaboration to ensure that semantic technologies can transition from prototypes to operational infrastructures supporting precision oncology. Clinical Trial: Not applicable - this study is a systematic review and did not involve a clinical trial.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.